ACC 2021

Electrophysiology

Favourable outcomes with transcatheter atrial appendage occlusion

Presented By

Dr Matthew Price, Scripps Clinic, USA

Trial

PROTECT AF, PREVAIL

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:31

Etripamil nasal spray significantly improves PSVT-related symptoms

Presented By

Dr Bruce Stambler, Piedmont Heart Institute, USA

Trial

Phase 3, NODE-301

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:38

Ablation-based rhythm control as effective as rate control in AF and HF

Presented By

Prof. Anthony Tang, University of Ottawa, Canada

Trial

RAFT-AF

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 14:41

Finerenone reduces the risk of AF onset in patients with CKD and diabetes

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 13:46

Heart Failure and Cardiomyopathy

PARADISE-MI: Sacubitril/valsartan not superior to ramipril in reducing HF events

Presented By

Prof. Marc Pfeffer, Brigham and Women’s Hospital, USA

Trial

Phase 3, PARADISE-MI

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:29

Older adults with heart failure benefit from rehabilitation programme

Presented By

Dr Dalane Kitzman , Wake Forest School of Medicine, NC, USA

Trial

REHAB-HF

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 21:42

Quality improvement intervention fails to improve care for patients with heart failure

Presented By

Prof. Adam DeVore, Duke University School of Medicine, USA

Trial

CONNECT-HF

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 20:54

Sacubitril/valsartan does not reduce NT-proBNP versus valsartan alone in HFrEF

Presented By

Prof. Douglas Mann, Washington School of Medicine, USA

Trial

Phase 4, LIFE

Conference

ACC 2021

9 July 2021 19:02

Novel use of ivabradine in reversible cardiomyopathy

Presented By

Dr Eric Torkildsen, Lehigh Valley Health Network, USA

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 18:15

Mavacamten significantly improves QoL of patients with hypertrophic cardiomyopathy

Presented By

Prof. John Spertus, Saint Luke’s Mid America Heart Institute, USA

Trial

Phase 3, EXPLORER-HCM

Conference

ACC 2021

Type

Peer-reviewed article

15 May 2021 22:34

Interventional and Structural Cardiology

Men and women benefit equally from early aspirin withdrawal following PCI

Presented By

Dr Birgit Vogel, Icahn School of Medicine, USA

Trial

TWILIGHT

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:24

Similar outcomes with fractional flow reserve and angiography-guided revascularisation

Presented By

Dr Etienne Puymirat, Hôpital Européen Georges-Pompidou

Trial

FLOWER-MI

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:30

TALOS-AMI: Exploring outcomes after switching to clopidogrel versus ticagrelor at 1 month from MI

Presented By

Prof. Kiyuk Chang, Seoul St. Mary’s Hospital, South Korea

Trial

TALOS-AMI

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 20:46

Clopidogrel monotherapy associated with better net outcomes relative to aspirin monotherapy 6-18 months after PCI

Presented By

Prof. Hyo-Soo Kim, Seoul National University Hospital, South Korea

Trial

HOST-EXAM

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 19:52

Ischaemic Heart Disease

No difference in ischaemic risk or bleeding with low vs high-dose aspirin for secondary prevention: Lessons and questions from the ADAPTABLE trial

Presented By

Prof. William Schuyler Jones , Duke Clinical Research Institute, USA

Trial

ADAPTABLE

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:03

Rivaroxaban reduces total ischaemic events after peripheral artery revascularisation

Presented By

Dr Rupert Bauersachs, Klinikum Darmstadt, Germany

Trial

VOYAGER PAD

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:13

Moderate hypothermia not superior to mild hypothermia following out-of-hospital cardiac arrest

Presented By

Dr Michel Le May , University of Ottawa, Canada

Trial

CAPITAL-CHILL

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 21:16

Better outcomes with invasive strategy if anatomic complete revascularisation is possible

Presented By

Dr Gregg Stone, Mount Sinai Medical Centre, USA

Trial

ISCHEMIA

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 10:20

Prevention and Health Promotion

STRENGTH trial fails to demonstrate cardioprotective effect of omega-3 fatty acids

Presented By

Dr Steven Nissen, Cleveland Clinic, USA

Trial

STRENGTH, REDUCE-IT

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:25

Evinacumab lowers triglyceride levels in severe hypertriglyceridaemia

Presented By

Dr Robert Rosenson, Icahn School of Medicine at Mount Sinai, USA

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:29

Health equity and the role of the cardiologist: 7 priorities to consider

Presented By

Prof. Michelle Albert, University of California, USA

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 17:39

COVID-19

Dapagliflozin fails to show a significant protective effect in COVID-19

Presented By

Prof. Mikhail Kosiborod, Saint Luke’s Mid America Heart Institute, USA

Trial

DARE-19

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:46

Therapeutic anticoagulation not superior to prophylactic anticoagulation in COVID-19

Presented By

Prof. Renato Lopes, Duke University Medical Center, USA

Trial

Coalition ACTION

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:02

Atorvastatin does not reduce mortality in COVID-19

Presented By

Dr Behnood Bikdeli, Yale University School of Medicine, USA

Trial

INSPIRATION

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 18:08

Valvular Heart Disease